Company Overview

Company name: Grays Pharmaceuticals
Description: Producer of medicinal cannabis intended to sell in the foreign markets. The company has made a joint venture in Lesotho to increase its production capacity and it will be used to treat symptoms of cancer, Parkinson’s, chrons as well as various neurological disorders, enabling clients to get cannabis at a reasonable price.
Year founded:
Parent company:
Industry: Healthcare | Group: | Code:
City: Pretoria
Country: South Africa

Financial Highlights

Start up capital raised (USD Million): 0.17
Business status: Startup
Ownership: Privately Held (backing)
Revenue (USD Million):
Gross profit (USD Million):
Net income (USD Million)
Enterprise value:
Earnings before interest, tax, depreciation and amortization (EBITDA):
Fiscal period:
Financing Status: The company announced it has raised ZAR 3 million and wants to raise ZAR 20 million of seed funding in total on an undisclosed date. The funds will be used to set-up infrastructure in to obtain SAPHRA license to cultivate before the market closes.
Number of active investors:
Profile last updated: 24-Apr-2020
Last known valuation:
Last known valuation date: